Acme United Corporation Recalls Med-Nap BZK Antiseptic Towelettes Due to CGMP Deviations
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Acme United Corporation has voluntarily recalled specific lots of Med-Nap BZK Antiseptic Towelettes nationwide due to deviations from Current Good Manufacturing Practice (CGMP) standards.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
Acme United Corporation has initiated a voluntary recall of Med-Nap BZK Antiseptic Towelettes. The recall was prompted by deviations from Current Good Manufacturing Practice (CGMP) requirements. The U.S. Food and Drug Administration (FDA) has classified this as a Class II recall, which was officially reported on March 11, 2026.
Which Products Are Affected
The recall affects Med-Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), sized 5" x 7", sold in bulk quantities of 1,000 units per package.
- Brand Name: Med-Nap
- NDC Number: 0924-0246-02
- UPC: 0092265940061
- Recall Number: D-0367-2026
- Affected Lot Numbers and Expiration Dates:
- Lot # MN23323 (Exp. Date Jul 2028)
- Lot # MN31323 (Exp. Date Oct 2028)
- Lot # MN21622 (Exp. Date Jul 2027)
- Lot # MN13123 (Exp. Date Apr 2028)
These products were distributed nationwide throughout the United States.
What You Should Do
Consumers, retailers, and healthcare facilities should immediately check their stock for the affected lot numbers listed above. If you possess any of the recalled products, you should stop using them and contact Acme United Corporation for instructions regarding the return or disposal of the items. The firm initiated the notification process via letter to its distributors and customers.
Why This Matters
Adherence to Current Good Manufacturing Practice (CGMP) is essential to ensure the safety, identity, strength, and quality of drug products. Deviations from these standards mean the manufacturing process may not have been sufficiently controlled, potentially compromising the product's integrity.
Source
Information provided by the FDA Enforcement Report.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.